Global Imbruvica Market 2024 by Company, Regions, Type and Application, Forecast to 2030
1 Market Overview
- 1.1 Product Overview and Scope of Imbruvica
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Imbruvica by Type
- 1.3.1 Overview: Global Imbruvica Market Size by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Global Imbruvica Consumption Value Market Share by Type in 2023
- 1.3.3 5 mg
- 1.3.4 10 mg
- 1.3.5 140 mg
- 1.4 Global Imbruvica Market by Application
- 1.4.1 Overview: Global Imbruvica Market Size by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Mantle Cell Lymphoma
- 1.4.3 Chronic Lymphocytic Leukemia
- 1.4.4 Waldenström's Macroglobulinemia
- 1.4.5 Relapsed/Refractory Marginal Zone Lymphoma
- 1.4.6 Chronic Graft-Versus-Host-Disease
- 1.5 Global Imbruvica Market Size & Forecast
- 1.6 Global Imbruvica Market Size and Forecast by Region
- 1.6.1 Global Imbruvica Market Size by Region: 2019 VS 2023 VS 2030
- 1.6.2 Global Imbruvica Market Size by Region, (2019-2030)
- 1.6.3 North America Imbruvica Market Size and Prospect (2019-2030)
- 1.6.4 Europe Imbruvica Market Size and Prospect (2019-2030)
- 1.6.5 Asia-Pacific Imbruvica Market Size and Prospect (2019-2030)
- 1.6.6 South America Imbruvica Market Size and Prospect (2019-2030)
- 1.6.7 Middle East and Africa Imbruvica Market Size and Prospect (2019-2030)
2 Company Profiles
- 2.1 AbbVie (Pharmacyclics)
- 2.1.1 AbbVie (Pharmacyclics) Details
- 2.1.2 AbbVie (Pharmacyclics) Major Business
- 2.1.3 AbbVie (Pharmacyclics) Imbruvica Product and Solutions
- 2.1.4 AbbVie (Pharmacyclics) Imbruvica Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 AbbVie (Pharmacyclics) Recent Developments and Future Plans
- 2.2 Johnson & Johnson (Janssen Biotech)
- 2.2.1 Johnson & Johnson (Janssen Biotech) Details
- 2.2.2 Johnson & Johnson (Janssen Biotech) Major Business
- 2.2.3 Johnson & Johnson (Janssen Biotech) Imbruvica Product and Solutions
- 2.2.4 Johnson & Johnson (Janssen Biotech) Imbruvica Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Johnson & Johnson (Janssen Biotech) Recent Developments and Future Plans
- 2.3 SP Laboratories
- 2.3.1 SP Laboratories Details
- 2.3.2 SP Laboratories Major Business
- 2.3.3 SP Laboratories Imbruvica Product and Solutions
- 2.3.4 SP Laboratories Imbruvica Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 SP Laboratories Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Imbruvica Revenue and Share by Players (2019-2024)
- 3.2 Market Share Analysis (2023)
- 3.2.1 Market Share of Imbruvica by Company Revenue
- 3.2.2 Top 3 Imbruvica Players Market Share in 2023
- 3.2.3 Top 6 Imbruvica Players Market Share in 2023
- 3.3 Imbruvica Market: Overall Company Footprint Analysis
- 3.3.1 Imbruvica Market: Region Footprint
- 3.3.2 Imbruvica Market: Company Product Type Footprint
- 3.3.3 Imbruvica Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Imbruvica Consumption Value and Market Share by Type (2019-2024)
- 4.2 Global Imbruvica Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
- 5.1 Global Imbruvica Consumption Value Market Share by Application (2019-2024)
- 5.2 Global Imbruvica Market Forecast by Application (2025-2030)
6 North America
- 6.1 North America Imbruvica Consumption Value by Type (2019-2030)
- 6.2 North America Imbruvica Consumption Value by Application (2019-2030)
- 6.3 North America Imbruvica Market Size by Country
- 6.3.1 North America Imbruvica Consumption Value by Country (2019-2030)
- 6.3.2 United States Imbruvica Market Size and Forecast (2019-2030)
- 6.3.3 Canada Imbruvica Market Size and Forecast (2019-2030)
- 6.3.4 Mexico Imbruvica Market Size and Forecast (2019-2030)
7 Europe
- 7.1 Europe Imbruvica Consumption Value by Type (2019-2030)
- 7.2 Europe Imbruvica Consumption Value by Application (2019-2030)
- 7.3 Europe Imbruvica Market Size by Country
- 7.3.1 Europe Imbruvica Consumption Value by Country (2019-2030)
- 7.3.2 Germany Imbruvica Market Size and Forecast (2019-2030)
- 7.3.3 France Imbruvica Market Size and Forecast (2019-2030)
- 7.3.4 United Kingdom Imbruvica Market Size and Forecast (2019-2030)
- 7.3.5 Russia Imbruvica Market Size and Forecast (2019-2030)
- 7.3.6 Italy Imbruvica Market Size and Forecast (2019-2030)
8 Asia-Pacific
- 8.1 Asia-Pacific Imbruvica Consumption Value by Type (2019-2030)
- 8.2 Asia-Pacific Imbruvica Consumption Value by Application (2019-2030)
- 8.3 Asia-Pacific Imbruvica Market Size by Region
- 8.3.1 Asia-Pacific Imbruvica Consumption Value by Region (2019-2030)
- 8.3.2 China Imbruvica Market Size and Forecast (2019-2030)
- 8.3.3 Japan Imbruvica Market Size and Forecast (2019-2030)
- 8.3.4 South Korea Imbruvica Market Size and Forecast (2019-2030)
- 8.3.5 India Imbruvica Market Size and Forecast (2019-2030)
- 8.3.6 Southeast Asia Imbruvica Market Size and Forecast (2019-2030)
- 8.3.7 Australia Imbruvica Market Size and Forecast (2019-2030)
9 South America
- 9.1 South America Imbruvica Consumption Value by Type (2019-2030)
- 9.2 South America Imbruvica Consumption Value by Application (2019-2030)
- 9.3 South America Imbruvica Market Size by Country
- 9.3.1 South America Imbruvica Consumption Value by Country (2019-2030)
- 9.3.2 Brazil Imbruvica Market Size and Forecast (2019-2030)
- 9.3.3 Argentina Imbruvica Market Size and Forecast (2019-2030)
10 Middle East & Africa
- 10.1 Middle East & Africa Imbruvica Consumption Value by Type (2019-2030)
- 10.2 Middle East & Africa Imbruvica Consumption Value by Application (2019-2030)
- 10.3 Middle East & Africa Imbruvica Market Size by Country
- 10.3.1 Middle East & Africa Imbruvica Consumption Value by Country (2019-2030)
- 10.3.2 Turkey Imbruvica Market Size and Forecast (2019-2030)
- 10.3.3 Saudi Arabia Imbruvica Market Size and Forecast (2019-2030)
- 10.3.4 UAE Imbruvica Market Size and Forecast (2019-2030)
11 Market Dynamics
- 11.1 Imbruvica Market Drivers
- 11.2 Imbruvica Market Restraints
- 11.3 Imbruvica Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Imbruvica Industry Chain
- 12.2 Imbruvica Upstream Analysis
- 12.3 Imbruvica Midstream Analysis
- 12.4 Imbruvica Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global Imbruvica market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Imbruvica is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK), that is important in B cells; the drug is used to treat B cell cancers like mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenström's macroglobulinemia.
The Global Info Research report includes an overview of the development of the Imbruvica industry chain, the market status of Mantle Cell Lymphoma (5 mg, 10 mg), Chronic Lymphocytic Leukemia (5 mg, 10 mg), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Imbruvica.
Regionally, the report analyzes the Imbruvica markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Imbruvica market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Imbruvica market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Imbruvica industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., 5 mg, 10 mg).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Imbruvica market.
Regional Analysis: The report involves examining the Imbruvica market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Imbruvica market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Imbruvica:
Company Analysis: Report covers individual Imbruvica players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Imbruvica This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia).
Technology Analysis: Report covers specific technologies relevant to Imbruvica. It assesses the current state, advancements, and potential future developments in Imbruvica areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Imbruvica market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Imbruvica market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
5 mg
10 mg
140 mg
Market segment by Application
Mantle Cell Lymphoma
Chronic Lymphocytic Leukemia
Waldenström's Macroglobulinemia
Relapsed/Refractory Marginal Zone Lymphoma
Chronic Graft-Versus-Host-Disease
Market segment by players, this report covers
AbbVie (Pharmacyclics)
Johnson & Johnson (Janssen Biotech)
SP Laboratories
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Imbruvica product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Imbruvica, with revenue, gross margin and global market share of Imbruvica from 2019 to 2024.
Chapter 3, the Imbruvica competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Imbruvica market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Imbruvica.
Chapter 13, to describe Imbruvica research findings and conclusion.